▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #4204 by analyst upside · 2026-09-29
CRON
Cronos Group Inc.
Healthcare · Market Cap $1B · P/E 17.9x
ANALYST PRICE TARGET
-27.5%
implied upside to consensus target
Current Price $3.41
Consensus Target $2.47
Bull Target $2.47
Bear Target $2.47
Analysts Covering 1
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
1
Hold
0
Sell
0
52-Week Low $2.28
52-Week High $3.61
YTD Return +26.3%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) 17.9x
Forward P/E N/A
EPS (TTM) $0.19
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $179M
Profit Margin 39.1%
52-WEEK RANGE
52-Week Low $2.28
52-Week High $3.61
Current Price $3.41
Bear Target $2.47
Bull Target $2.47
● Now $3.41 ● Target $2.47
TRADING DATA
Avg Volume 1.1M
YTD Return +26.3%
Analyst Count 1
Consensus Buy
Upside to Target -27.5%
Last Updated 2026-09-29

ANALYST SUMMARY

Cronos Group Inc. (CRON) is currently trading at $3.41 with a Wall Street consensus price target of $2.47, which is 27.5% below the current price over the next 12 months. 1 analysts currently cover CRON, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $2.47, while the most cautious has a target of $2.47.

CRON operates in the Healthcare sector with a market capitalisation of $1B. The stock is up 26.3% year-to-date and is currently trading near the upper end of its 52-week range of $2.28 – $3.61.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
40
out of 100
Coverage depth
5/30
Consensus clarity
8/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →